ArticleDermatology and therapy2022

Pooled Safety Analysis of Baricitinib in Adult Participants with Atopic Dermatitis in the Japanese Subpopulation from Six Randomized Clinical Trials.

Norito Katoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.